Intensity Therapeutics, Inc. (INTS)
4.23
-0.02
(-0.47%)
USD |
NASDAQ |
Aug 31, 12:20
Intensity Therapeutics Shareholders Equity (Quarterly) : 9.214M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.214M |
| March 31, 2026 | 9.979M |
| December 31, 2025 | 11.88M |
| September 30, 2025 | 7.222M |
| June 30, 2025 | 2.184M |
| March 31, 2025 | 0.334M |
| December 31, 2024 | 2.918M |
| September 30, 2024 | 2.779M |
| June 30, 2024 | 5.345M |
| March 31, 2024 | 9.722M |
| December 31, 2023 | 13.16M |
| September 30, 2023 | 15.91M |
| Date | Value |
|---|---|
| June 30, 2023 | 15.13M |
| March 31, 2023 | -5.962M |
| December 31, 2022 | -5.097M |
| September 30, 2022 | -4.214M |
| June 30, 2022 | -2.480M |
| March 31, 2022 | -0.776M |
| December 31, 2021 | 1.316M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | 7.117M |
| December 31, 2020 | 8.492M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.52M |
| Total Liabilities (Quarterly) | 2.307M |
| Debt to Equity Ratio | 0.0103 |
| Current Ratio | 5.002 |
| Net Debt Paydown Yield | 0.06% |